The announced schedule for 2023 TC, WG, and US TAG meetings is below. Meetings will be added as they are announced. All times are listed as ET. Please register for any meetings that you plan to attend (via Livelink for the TC276/WG meetings, or by emailing Clare for US TAG/WG. meetings). If you have any questions, please contact Clare (clare.allocca [at] nist.gov) or Sheng (sheng.lin-gibson [at] nist.gov). Click here to learn how to get involved.
Technical Committee (TC) / Working Group (WG) |
Agenda |
Date(s) |
ISO/TC276 Biotechnology |
TC-level Policy & Decisions, WG Summaries, Liaison Reports |
17 June 2023 |
WG2 Biobanks & bioresources |
All Projects not being balloted at the time of the meeting |
12-14 June 2023 |
WG3 Analytical methods |
13-16 June 2023 |
|
WG4 Bioprocessing |
12-13 June 2023 |
|
WG5 Data processing & integration |
13, 15-16 June 2023 |
Please join us for the next international ISO/TC276 Plenary and Working Group (WG) Meetings, to be held on 12-17 June 2023, in Atlanta (there is a virtual option as well). This is your opportunity to understand global perspectives on the direction of all projects in the TC276 Work Programme. This is also the event during which international decisions regarding progress will be discussed.
We encourage you to consider participation in one or more of these meetings. Specific schedules for each working group will soon be available on our documents list. Further information may be found here, and specific questions can be addressed by contacting Brian Montgomery, Clare Allocca, or Sheng Lin-Gibson.
The accomplishments of ISO/TC276 are exemplified by the publication of 26 standards with an additional 20+ standards under development. Standards published by ISO/TC276 support regenerative medicine, precision medicine, synthetic biology, and the broader bioeconomy. In particular, many standards published by ISO/TC276 are designed to facilitate product development, reduce time-to-market, and support regulatory approval, such as those to be recognized by the forthcoming Voluntary Consensus Standards Recognition Program for Regenerative Medicine Therapies, a program that aims to support the use of standards in FDA regulatory submissions. A complete list of the TC276 standards portfolio can be found here.